DSGN is currently covered by 2 analysts with an average price target of $20.5. This is a potential upside of $11.48 (127.27%) from yesterday's end of day stock price of $9.02.
Design Therapeutics's activity chart (see below) currently has 32 price targets and 31 ratings on display. The stock rating distribution of DSGN is 100% BUY.
Analysts' price targets on this stock were met 46.67% of the time, taking 260.8 days on average.
Highest price target for DSGN is $22, Lowest price target is $19, average price target is $20.5.
Most recent stock forecast was given by LEONID TIMASHEV from RBC on 05-Nov-2026. First documented stock forecast 20-Apr-2021.
Currently out of the existing stock ratings of DSGN, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Mar-2026
$19
$9.98 (110.64%)
$20
17 days ago
(05-Nov-2026)
7/12 (58.33%)
$9.33 (96.48%)
150
Buy Since 20-Apr-2021
$22
$12.98 (143.90%)
$22
6 months 4 days ago
(18-May-2026)
0/4 (0%)
$11.3 (105.61%)
Hold Since 07-May-2024
$12
2 years 6 months 15 days ago
(07-May-2024)
1/4 (25%)
$7.31 (155.86%)
699
Hold Since 14-Nov-2023
$5
$6
3 years 8 days ago
(14-Nov-2023)
3/6 (50%)
$2.71 (118.34%)
247
Sell Since 19-Jan-2022
$6
$10
4 years 5 months 29 days ago
(24-May-2022)
2/2 (100%)
$-5.92 (-49.66%)
208
What is DSGN (Design Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on DSGN (Design Therapeutics)?
Which analyst has the lowest performance score on DSGN (Design Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DSGN (Design Therapeutics)?
Which analyst is the currently most bullish on DSGN (Design Therapeutics)?
Which analyst is the currently most reserved on DSGN (Design Therapeutics)?